Skip to main content
. 2007 Jan 23;96(2):231–240. doi: 10.1038/sj.bjc.6603549

Table 2. Induction of apoptosis by OHP, TFT or both drugs in WiDr, H630 and SW1116 cells.

  Cell line
Drug Treatment WiDr H630 SW1116
Control 2.3±0.6** 1.6±0.3** 2.9±0.2**
TFT IC75 72 h 16.2±2.5 6.7±0.5** 10.6±1.7
OHP IC75 72 h 13.2±1.7 8.2±3.0 13.7±2.2
OHP IC75+TFT IC75 72 h 18.8±3.1* 13.1±1.0* 20.6±1.5**
OHP IC75 48 h alone 8.9±1.2* 3.5±0.3** 7.0±0.7**
TFT IC75 24 h>OHP IC75 48 h 9.3±1.1* 7.0±0.7* 9.0±0.9*

The cells were exposed 72 h to [IC75] of the drugs, either alone or in combination. These concentrations were: WiDr: 25 μM TFT, 10 μM OHP; H630: 10 μM TFT, 3.5 μM OHP and SW1116: 100 μM TFT, 10 μM OHP. Values (%) represent [apoptosis population]/[total cell population] and are expressed as means±s.e.m. (n=3). Compared to OHP alone: *P<0.05; **P<0.01 ((un)paired t-test).